Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Paola Bustillos

Urology El Paso, TX Medical Doctor

NPI 1922599778 CMS profile 11441271

3100 N Lee Trevino Dr Ste G, El Paso, TX 79936

Open in the dashboard

General payments

$8,425

96 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paola Bustillos of El Paso, TX is reported in the CMS Open Payments database as having received $8,425 across 96 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,468 41
2024 General $1,179 34
2023 General $778 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paola Bustillos
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Paola Bustillos were reported at $6,468. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Paola Bustillos Urology median Middle half National median
2019 $0 $480 $147–$1,201 $163
2020 $0 $246 $87–$645 $114
2021 $0 $358 $111–$1,000 $132
2022 $0 $476 $143–$1,263 $149
2023 $778 $560 $168–$1,461 $160
2024 $1,179 $563 $170–$1,464 $164
2025 $6,468 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Intuitive Surgical, Inc. $5,951 17 payments
  2. Axonics Modulation Technologies, Inc. $590 11 payments
  3. AbbVie, Inc. $376 16 payments
  4. Calyxo, Inc. $252 7 payments
  5. Ge Healthcare $186 2 payments
  6. Boston Scientific Corporation $172 8 payments
  7. Valencia Technologies Corporation $154 1 payment
  8. Sumitomo Pharma America, Inc. $148 7 payments
  9. PROCEPT BioRobotics Corporation $118 4 payments
  10. Ferring Pharmaceuticals Inc. $99 6 payments
  11. Other $378 17 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $3,288 86 payments
  2. Education $3,000 2 payments
  3. Travel and Lodging $2,137 8 payments
Products named General payments · program years 2023–2025
  1. DA VINCI SP $3,000 2 payments
  2. Da Vinci Surgical System $2,951 15 payments
  3. Axonics $612 12 payments
  4. BOTOX $340 14 payments
  5. CVAC ASPIRATION SYSTEM $252 7 payments
  6. eCoin Device Kit $154 1 payment
  7. GEMTESA $148 7 payments
  8. AQUABEAM SYSTEM $118 4 payments
  9. ADSTILADRIN $99 6 payments
  10. KEYTRUDA $75 4 payments
  11. Other $442 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

725

Median for Urology: 1,053

Drug cost

$53,774

Median for Urology: $101,464

Branded share of claims

25.8%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gemtesa Vibegron Brand 20 $20,865
Myrbetriq Mirabegron Brand 19 $18,976
Estradiol Generic 97 $6,040
Solifenacin Succinate Generic 70 $3,616
Tamsulosin Hcl Generic 179 $1,667
Cefdinir Generic 60 $620
Ciprofloxacin Hcl Generic 75 $587
Finasteride Generic 27 $383
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 16 $320
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 102 $313

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$37,291

Medicare's payments for the services billed

Medicare patients

127

Average age 72

Services billed

822

63 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 50%
Chronic kidney disease 43%
Arthritis 43%
Ischemic heart disease 27%
Depression 25%
Cancer 23%
Osteoporosis 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $71
$71 — —
ADSTILADRIN
  • Ferring Pharmaceuticals Inc. $49
$49 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $44
$44 — —
GEMTESA
  • Sumitomo Pharma America, Inc. $37
$37 20 —
PLUVICTO
  • Novartis Pharmaceuticals Corporation $29
$29 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

96 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record